Cancer stages describe how far a cancer has grown and whether it has spread beyond where it started. They range from stage 0 (abnormal cells that haven’t invaded surrounding tissue) to stage IV (cancer that has spread to distant parts of the body). The stage assigned at diagnosis is one of the most important factors in determining treatment options and outlook.
How Staging Works: The TNM System
Most solid cancers are staged using a system called TNM, which stands for three things doctors measure. T describes the size and extent of the primary tumor, rated from T1 (small) to T4 (large or deeply grown into nearby tissue). N describes whether cancer has reached nearby lymph nodes, small immune system organs scattered throughout your body that often serve as the first stop for spreading cancer cells. N0 means no lymph nodes are involved; N1 through N3 means progressively more nodes contain cancer. M is simply whether the cancer has metastasized, meaning traveled to a distant organ. M0 means it hasn’t. M1 means it has.
These three scores are combined to assign an overall stage, from 0 through IV. The system is maintained by the American Joint Committee on Cancer (AJCC), which recently shifted from printed edition manuals to a continuously updated Version 9 system. Updated staging rules for specific cancer sites now go into effect on a rolling basis rather than all at once.
Stage 0: Abnormal Cells, No Invasion
Stage 0, sometimes called carcinoma in situ, means abnormal cells that look like cancer under a microscope have been found, but they remain confined to the exact layer of tissue where they first formed. They haven’t pushed into surrounding tissue. Think of it as a precancerous condition: the cells have the potential to become invasive cancer, but they haven’t crossed that line yet. Stage 0 is most commonly identified in breast, cervical, and skin cancers, and it’s typically treated with minor surgery or close monitoring.
Stages I and II: Early, Localized Cancer
Stage I generally means a small tumor that hasn’t grown deeply into surrounding tissue and hasn’t reached any lymph nodes. For many cancers, this is a tumor confined to the organ where it started, with no sign of spread. Stage II indicates either a larger tumor or one that has started to grow into nearby tissue, sometimes with a small number of nearby lymph nodes involved. The cancer is still considered localized or regional at these stages.
The practical significance is substantial. People diagnosed with stage I melanoma, for example, have a life expectancy nearly identical to someone without cancer. Stage I Hodgkin lymphoma shows a similar pattern, especially in younger patients. Treatment at these stages often involves surgery, sometimes followed by radiation or a short course of additional therapy, with the realistic goal of a complete cure.
Stage III: Larger or Regionally Spread
Stage III typically means the cancer is larger, has grown more extensively into nearby tissue, or has spread to several regional lymph nodes. It hasn’t traveled to distant organs. This is sometimes described as locally advanced cancer. Treatment usually becomes more intensive at this stage, often combining surgery with chemotherapy, radiation, or both.
The outlook at stage III varies enormously depending on the type of cancer. For some cancers, the difference in life expectancy between stages I through III is relatively gradual, with each step up representing a modest reduction. For others, stage III marks a sharper drop. The key distinction from stage IV is that stage III cancer is still confined to the general area where it started, which keeps more treatment options on the table.
Stage IV: Distant Spread
Stage IV means cancer has spread to organs or tissues far from the original tumor. This is metastatic cancer. Common destinations include the lungs, liver, bones, and brain, though the specific sites depend on the cancer type. A stage IV diagnosis always involves an M1 classification in the TNM system, regardless of the tumor’s size or lymph node involvement.
The impact on prognosis can be dramatic. Research published in BMJ Oncology found that a woman diagnosed with colorectal cancer at age 40 could expect to live past age 71 if diagnosed at stages I through III, but only to about age 46 if diagnosed at stage IV. For cancers like prostate, bladder, and colorectal, the gap in life expectancy between stages I through III and stage IV is especially large. For other cancers, the reduction in life expectancy is more evenly distributed across each stage increase.
Stage IV cancer is typically treated with systemic therapies that reach the entire body, including chemotherapy, immunotherapy, and targeted drugs. The goal may shift from curing the cancer to controlling its growth and maintaining quality of life, though some stage IV cancers do respond well to modern treatments.
How Doctors Determine Your Stage
Staging relies on a combination of imaging tests and tissue samples. CT scans create detailed 3-D images of your organs. MRI uses magnetic fields and radio waves to produce high-resolution pictures, particularly useful for soft tissue. PET scans highlight areas of high metabolic activity, which can reveal cancer that might not show up on other scans. Bone scans detect whether cancer has spread to the skeleton. Ultrasound and standard X-rays round out the imaging toolkit.
Blood tests also play a role. Tumor marker tests measure substances that cancer cells release into the bloodstream. Complete blood counts and blood chemistry panels can flag abnormalities that suggest cancer involvement. Liquid biopsies, a newer approach, look for fragments of tumor DNA circulating in the blood. For blood cancers like leukemia and lymphoma, specialized tests called immunophenotyping identify cancer cells based on markers on their surface.
The stage may be assessed more than once. An initial clinical stage is assigned based on imaging, physical exams, and biopsies before any surgery. If surgery is performed, doctors examine the removed tissue under a microscope to assign a pathological stage, which is generally considered more precise. Sometimes the pathological stage differs from the clinical stage, either up or down, because imaging can’t capture every microscopic detail.
Blood Cancers Follow Different Rules
The TNM system works for solid tumors, but blood cancers like leukemia and lymphoma don’t form a single mass that can be measured by size. Lymphomas use the Lugano classification, which stages the disease based on how many lymph node groups are involved and whether the cancer is above or below the diaphragm (the muscle separating your chest from your abdomen). Chronic lymphocytic leukemia staging factors in signs like swollen lymph nodes, enlarged organs, low red blood cell counts, and low platelet counts rather than tumor dimensions.
Why the Stage Matters for You
Your cancer stage shapes nearly every decision that follows. It determines which treatments are appropriate, how aggressive those treatments need to be, and what the realistic range of outcomes looks like. It also provides a common language: when your oncologist says “stage II,” any other oncologist in the world understands what that means in terms of how far the cancer has progressed.
One important detail: your stage at diagnosis doesn’t change, even if the cancer later grows or shrinks. If you’re diagnosed at stage II and the cancer later spreads, you’d be described as having “stage II cancer with metastatic recurrence,” not reclassified as stage IV. This preserves the original baseline so doctors can track how the disease has behaved over time. Stage is also just one factor in prognosis. Age, overall health, specific genetic features of the tumor, and how the cancer responds to initial treatment all influence outcomes alongside the stage number.